The analysis of YY1 and BCL2L15 expression following CRC samples stratification based on cancer aggressiveness (i.e., metastasis vs. primary, mesenchymal vs. epithelial) was demonstrated to be a significant discriminator. This evidence concerns the gene BCL2L15 and cancer.